Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
T-DXd Based Therapy Followed by Endocrine Therapy Plus Dual HER2 Blockade in First-line HER2+/ HR+ Metastatic Breast Cancer and Retreatment With T-DXd
Apply
T-DXd & Pertuzumab
T-DXd Based Therapy Followed by Endocrine Therapy Plus Dual HER2 Blockade in First-line HER2+/ HR+ Metastatic Breast Cancer and Retreatment With T-DXd
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step